A FOUR WEEK, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, PHASE 2A STUDY OF VARENICLINE TARTRATE (CP-526,555) IN THE TREATMENT OF POST-HERPETIC NEURALGIA

Mise à jour : Il y a 4 ans
Référence : EUCTR2008-002208-24

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

1.To evaluate the analgesic efficacy of varenicline versus placebo in patients with postherpetic neuralgia (PHN) 2.To evaluate the safety and tolerability of varenicline versus placebo in patients with postherpetic neuralgia. 3.To characterize the pharmacokinetics of varenicline in patients with post-herpetic neuralgia.


Critère d'inclusion

  • Post-Herpetic Neuralgia

Liens